Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-06-07
2011-06-07
Lu, Frank W (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C435S091510, C435S287200, C536S023100, C536S024300, C536S024330
Reexamination Certificate
active
07955800
ABSTRACT:
Methods for determining a tumor in a human is disclosed. Also disclosed are methods for identifying adenocarcinoma, and methods for identifying squamous cell carcinoma in a human tumor sample. In addition, methods for predicting prognosis of metastasis and survival in a human having a tumor is disclosed.
REFERENCES:
Hao et al., STAT1 and Survivin Expression in Full Lymph Node Examined Gastric Cancer by Using Tissue Microarray Technique. The Chinese-German Journal of Clinical Oncology, 5, 249-252, 2006.
Sun et al., Gene expression prefiling on lung cancer outcome prediction: present clinical value and future premise. Cancer Epidemiol. Biomarkers Prev., 15, 2063-2068, 2006.
Beane et al., Clinical impact of high-throughput gene expression studies in lung cancer. J. Thorac. Oncol., 4, 109-118, 2009.
Newnham et al., Molecular profiling of non-small cell lung cancer: of what value in clinical practice? Heart, lung, and Circulation, 17, 451-462, 2008.
Subramanian et al., Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use? Journal of National Cancer Institute, 102, 464-474, Apr. 2010.
Taniwaki et al., Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. International Journal of oncology, 29, 567-575, 2006.
Ingersoll et al., Comparison of gene expression profiles between human and mouse monocyte subsets. eBlood, 115, e10-e19, 2010.
Jemal et al., Cancer Statistics, 2005; CA Cancer Journal for Clinicians (2005) vol. 55, pp. 10-30.
Parkin et al., Cancer burden in the year 2000. The global picture; European Journal of Cancer (2001) vol. 37, pp. S4-S66.
Hoffman et al., Lung cancer; The Lancet, (2000), vol. 355, pp. 479-485.
Mountain, Revisions in the International System for Staging Lung Cancer; Chest (1997), vol. 111, pp. 1710-1717.
Naruke et al., Prognosis and survival in resected lung carcinoma based on the new international staging system; J Thora Cardiovasc Surg (1988), vol. 96, pp. 440-447.
Beer et al., Gene-expression profiles predict survival of patients with lung adenocarcinoma; Nature Medicine (2002), vol. 8, pp. 816-824.
Wigle et al., Molecular Profiling of Non-Small Cell Lung Cancer and Correlation with Disease-free Survival; Cancer Research (2002), vol. 62, pp. 3005-3008.
Ramaswamy et al., Translating Cancer Genomics into Clinical Oncology; N. Engl. J. Med. (2002), vol. 350, pp. 1814-1816.
Endoh et al., Prognostic Model of Pulmonary Adenocarcinoma by Expression Profiling of Eight Genes As Determined by Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction; Journal of Clinical Oncology (2004), vol. 22, pp. 811-819.
Bhattacharjee et al., Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses; Proc. Natl. Acad. Sci. (2001), vol. 98, pp. 13790-13795.
Garber et al., Diversity of gene expression in adenocarcinoma of the lung; Proc. Natl. Aca. Sci. (2001), vol. 98, pp. 13784-13789.
McDoniels-Silvers et al., Differential Gene Expression in Human Lung Adenocarcinomas and Squamous Cell Carcinomas; Clinical Cancer Research (2002), vol. 8, pp. 1127-1138.
McDoniels-Silvers et al., Differential Expression of Critical Cellular Genes in Human Lung Adenocarcinomas and Squamous Cell Carcinomas in Comparison to Normal Lung Tissues; Neoplasia (2002), vol. 4, pp. 141-150.
Nacht et al., Molecular characteristics of non-small cell lung cancer; Proc. Natl. Acad. Sci. (2001), vol. 98, pp. 15203-15208.
Chou et al., Mutation in the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor Is a Predictive and prognostic Factor for Gefitinib Treatment in Patients with Non-Small Cell Lung Cancer; Clinical Cancer Research (2005), vol. 11, pp. 3750-3757.
Huang et al., High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non-Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan; Clinical Cancer Research (2004), vol. 10, pp. 8195-8203.
Shigematsu et al., Clinical and Biological Features Associated with Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers; Journal of the National Cancer Institute (2005), vol. 97, pp. 339-346.
Chen et al., Global Analysis of Gene Expression in Invasion by a Lung Cancer Model; Cancer Research (2001), vol. 61, pp. 5223-5230.
Chen et al., Profiling Expression Patterns and Isolating Differentially Expressed Genes by cDNA Microarray System with Colorimetry Detection; Genomcs (1998), vol. 51, pp. 313-324.
Chen et al., Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression; Journal of Clinical Oncology (2005), vol. 23, pp. 953-964.
Bolstad et al., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias; Bioinformatics (2003), vol. 19, pp. 185-193.
Benjamini et al., Controlling the False Discovery rate: A Practical and Powerful Approach to Multiple Testing; Journal of the Royal Statistical Society, Series B (1995), vol. 57, pp. 289-300.
Dudoit et al., Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data; Journal of the American Statistical Association (2002), vol. 97, pp. 77-87.
Bender et al., Caveolin-1 Levels Are Down-Regulated in Human Colon Tumors, and Ectopic Expression of Caveolin-1 in Colon Carcinoma Cell Lines Reduces Cell Tumorigenicity; Cancer Research (2000), vol. 60, pp. 5870-5878.
Ho et al., Up-Regulated Caveolin-1 Accentuates the Metastasis Capability of Lung Adenocarcinoma by Inducing Filopodia Formation; American Journal of Pathology (2002), vol. 161, pp. 1647-1656.
Sagara et al., Clinical significance of Caveolin-1, Caveolin-2 and HER2
eu mRNA expression in human breast cancer; British Journal of Cancer (2004), vol. 91, pp. 959-965.
Wiechen et al., Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in Sarcomas; American Journal of Pathology (2001), vol. 158, pp. 833-839.
Gouyer et al., Tissue Inhibitor of Metalloproteinase 1 Is an Independent Predictor of Prognosis in Patients with Nonsmall Cell Lung Carcinoma who Undergo Resection with Curative Intent; American Cancer Society (2005), vol. 103, pp. 1676-1684.
Spitz et al., Serum Insulin-like Growth Factor (IGF) and IGF-Binding Protein Levels and Risk of Lung Cancer: A Case-Control Study Nested in the β-Carotene and Retinol Efficacy Trial Cohort; Cancer Epidemiology, Biomarkers Prevention (2002), vol. 11, pp. 1413-1418.
Renehan et al., Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis; The Lancet (2004), vol. 363, pp. 1346-1353.
Dudoit et al., Statistical Methods for Identifying Differentially Expressed Genes in Replicated cDNA Microarray Experiments; Statistica Sinica (2002), vol. 12, pp. 111-139.
Troyanskaya et al., Nonparametric methods for identifying differentially expressed genes in microarray data; Oxford University Press (2002), vol. 18, pp. 1454-1461.
Petty et al., Gene Expression Profiling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application; Clinical Cancer Research (2004), vol. 10, pp. 3237-3248.
Poller et al., Production and Characterization of a Polyclonal Antibody to the c-erbB-3 Protein: examination of c-erbB-3 Protein Expression in Adenocarcinomas; Journal of Pathology (1992), vol. 168, pp. 275-280.
Sithanandam et al., Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549; Oncogene (2005), vol. 24, pp. 1847-1859.
Cox et al., Regression Models and Life-Tables; Journal of the Royal Statistical Society. Series B (1972), vol. 34, pp. 187-220.
Zhang et al., Recursive partitioning for tumor classification with gene expression microarray data; Proc. National Academy of Science (2001), vol. 98, pp. 6730-6735.
Chen Hsuan-Yu
Chen Jeremy J. W.
Chou Yeh-Tze
Terng Harn-Jing
Yang Pan-Chyr
Advpharma Inc.
Intellectual Property Connections, Inc.
Lu Frank W
Saunders Hsiu-Ming
LandOfFree
Metastasis-associated gene profiling for identification of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metastasis-associated gene profiling for identification of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metastasis-associated gene profiling for identification of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2675910